
Johnson & Johnson
JNJ 245.84 (0.00%) 0.00
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $592.45(B)
EV: $619.66(B)
Total Equity: $81.54(B)
Earnings date: Apr-14-2026
P/E: 22.09
Forward P/E: 21.32
P/FCF: 30.05
P/S: 6.28
P/B: 7.26
EPS: $11.1
EPS (fwd): $11.5
FCF/share: $8.2
Revenue/share: $39.1
Book value/share: $33.9
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.60
Current Ratio: 1.00
Gross margin: 68.1%
Operating margin: 26.2%
Net margin: 28.5%
Dividend/share: $5.1
Div. yield: 2.09%
TTM Financials
Income (TTM)
Revenue$94.19(B)
Gross profit$64.13(B)
EBITDA$33.84(B)
Net income$26.80(B)
Gross margin68.1%
Operating margin26.2%
Net margin28.5%
Shares outstanding2.41(B)
Balance sheet
Total assets$199.21(B)
Current assets$55.62(B)
Total liabilities$117.67(B)
Current liabilities$54.13(B)
Cash & Short-term inv.$20.10(B)
Long-term debt$39.44(B)
Total intangibles$99.17(B)
PP&E$24.47(B)
Cash flow (TTM)
FCF$19.70(B)
CapEx$-4.83(B)
Dividends paid$-12.38(B)
Stock issued$3.42(B)
Stock repurchased$-5.95(B)
Stock-based comp.$1.35(B)
Debt issued$23.72(B)
Debt repaid$-14.09(B)
